Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.’s Net Profit Rose 32.2% in First Half of 2022

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (浙江莎普爱思药业股份有限公司) (603168.SH) reported a net profit of 35.6 million yuan in the first half of 2022, up 32.2% year-on-year.

Meanwhile, the company posted 280.1 million yuan in revenue, down 11.6% year-on-year.

At the end of the reporting period, it had 1.5 billion yuan in total assets and 152.9 million yuan in total liabilities, with a liability-to-asset ratio of 9.9%.